Nexalin Technology (NXL) Accounts Payables (2021 - 2026)
Nexalin Technology's (NXL) quarterly Accounts Payables came in at $168099.0 in Q1 2026, down 7.33% year-on-year from $181394.0 in Q1 2025, and down 31.27% quarter-over-quarter from $244579.0 in Q4 2025.
Nexalin Technology (NXL) Accounts Payables (2021 - 2026) Analysis & Trends
Nexalin Technology's Accounts Payables history runs 6 years deep, the most recent figure standing at $168099.0 for Q1 2026.
- On a quarterly basis, Accounts Payables fell 7.33% year-over-year to $168099.0 in Q1 2026; TTM through Mar 2026 was $168099.0, a 7.33% decrease from a year earlier, with the FY2025 full-year figure at $244579.0, up 56.83% from the prior year.
- Accounts Payables retreated to $168099.0 in Q1 2026 per NXL's latest filing, from $244579.0 in the prior quarter.
- Across five years, Accounts Payables topped out at $788293.0 in Q3 2022 and bottomed at $48501.0 in Q2 2023.
- The 5-year median for Accounts Payables is $159534.0 (2023), against an average of $216352.4.
- Across the five-year window, Accounts Payables plunged 90.8% in 2023 and jumped 176.69% in 2024, its largest moves.
- Year by year, Accounts Payables stood at $658367.0 in 2022, then tumbled by 75.77% to $159534.0 in 2023, then slipped by 2.25% to $155949.0 in 2024, then surged by 56.83% to $244579.0 in 2025, then sank by 31.27% to $168099.0 in 2026.
- Per Business Quant, the three latest NXL Accounts Payables figures stand at $168099.0 (Q1 2026), $244579.0 (Q4 2025), and $67493.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 4.68 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.59 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.14 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 181.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 2.33 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 3.41 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.18 Bn |
| 10 | Nexalin Technology | 9.32 Mn | 6.61 Mn | 13,133.00 | 168,099.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 168,099.00 |
| Dec 31, 2025 | 244,579.00 |
| Sep 30, 2025 | 67,493.00 |
| Jun 30, 2025 | 240,580.00 |
| Mar 31, 2025 | 181,394.00 |
| Dec 31, 2024 | 155,949.00 |
| Sep 30, 2024 | 166,542.00 |
| Jun 30, 2024 | 87,138.00 |
| Mar 31, 2024 | 151,510.00 |
| Dec 31, 2023 | 159,534.00 |
| Sep 30, 2023 | 72,549.00 |
| Jun 30, 2023 | 48,501.00 |
| Mar 31, 2023 | 54,758.00 |
| Dec 31, 2022 | 658,367.00 |
| Sep 30, 2022 | 788,293.00 |
| Dec 31, 2021 | 843,794.00 |